At a glance
- Originator Ipsen
- Developer GSK; Ipsen
- Class Antiarrhythmics
- Mechanism of Action Platelet activating factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Ischaemic heart disorders; Stroke
Most Recent Events
- 15 Mar 1995 Discontinued-Preclinical for Stroke in United Kingdom (Unknown route)